New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms

New insights into how a gene causes damage could impact future drug development

A new center at Gladstone aims to find unforeseen uses for existing drugs

E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders